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Introduction
MAP kinase (MAPK) 1 cascades convey a signal in the form of phosphorylation events.
MAPKs are phosphorylated by MAP kinase kinases (MAPKKs), phosphorylate various targets, and are dephosphorylated and inactivated by several MAPK-phosphatases (MKPs). There are three major subgroups in the MAPK family, ERK, p38 and JNK/SAPK. ERK is activated mainly by mitogenic stimuli, whereas p38 and JNK/SAPK are activated mainly by stress stimuli or inflammatory cytokines.
(1-10). The signal must be transduced with high efficiency and specificity. The molecular basis for this accurate signal transduction has been addressed in recent years.
MAPKs form a complex with their cognate MAPKKs, substrates, and phosphatases (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . The complex formation is distinct from a transient enzyme-substrate interaction through the active center. For example, a complex formation between MEK1 (a MAPKK specific for ERK) and ERK is achieved through an N-terminal portion of MEK1 outside its catalytic domain (12) . A C-terminal portion outside the catalytic domain of RSK (a MAPKAPK specific for ERK) is required for a complex formation with ERK2 (16, 19, 28) . The ability to form a complex well correlates with the enzymatic specificity (13, 16, 19, 24, (29) (30) (31) (32) (33) . Such a complex formation is called a docking interaction, which is thought to regulate the enzymatic efficiency and specificity in the MAPK pathways. Recent studies provided cues to understand the molecular nature of the docking interaction. We and others identified a conserved MAPK-docking motif in the primary sequences of MAPK-interacting molecules (11, 14, (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . Furthermore, we have identified a docking site on MAPKs, which is located on the opposite side from the active center of the molecules in the steric structure and in the C-terminal portion of MAPKs in the primary sequence (22) . As this site is reactions. The CD domain solely, however, does not determine the docking specificity (22, 23) . In search of another site on MAPKs that might regulate the docking specificity, we identified then a site near the CD domain in the steric structure on MAPKs, and called it the ED site (23) . When both the CD domain and the ED site of ERK2 are engineered to mimic those of p38, the docking specificity is converted to the p38-type in the case of docking to some MAPKAPKs. We proposed thus a concept of a docking groove, which is composed of the CD domain, the ED site and the surrounding amino acids. While the CD domain is commonly important for every docking interaction, the ED site is differently utilized (23) . The next open question is then which region on the MAPK-interacting molecules corresponds to the docking groove of MAPKs.
MKPs belong to a family of dual specificity phosphatases, and specifically dephosphorylate both threonine and tyrosine residues in the P-loop of MAPKs. They share sequence homology and are highly specific for MAPKs, but differ in the substrate specificity, tissue distribution, subcellular localization, and inducibility by extracellular stimuli (34) (35) (36) . MKPs have been shown to play important roles in regulating the function of the MAPK family (37, 38) . In mammals, ten members of MKPs have been reported, and they must be precisely regulated in their substrate specificity to avoid unexpected inactivation of MAPKs. MKPs are mainly composed of two domains, an N-terminal rhodanese-fold and a C-terminal catalytic domain. The former is responsible for their selective docking to members of the MAPK family. As the catalytic domain alone does not show strict selectivity towards the members of MAPK family (13, 31) , the N-terminal domain of MKPs plays a major role in regulating their enzymatic specificity in vivo through docking interaction with MAPKs.
MKP is unique in this point among MAPK-interacting molecules. MAPKs. This modular structure of a docking surface of MKPs proposed here may be a molecular basis explaining the specificity of the action of MKPs towards the MAPK family.
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Results

Both the CD domain and the ED site important for docking interaction of MAPKs with CL100/MKP-1
We previously demonstrated that both the CD domain and the ED site of p38 and ERK
MAPKs are important for their interactions with MKP-3 (an MKP specific for ERK) and MKP-5 (an MKP specific for p38 and JNK/SAPK) (23) . Here, we extended our analysis to other MKPs, CL100/MKP-1 (also known as 3CH134) (39, 40) and MKP-7
which we have recently identified (24) . CL100 is thought to act preferentially on JNK/SAPK and p38, and weakly on ERK. In contrast, like MKP-5, MKP-7 acts specifically on JNK/SAPK and p38, and not on ERK. We used three mutant forms of ERK2: ERK2 SD in which a serine residue in the CD domain (Ser 323) was replaced by aspartic acid to mimic the CD domain of p38; ERK2 TETD in which the ED site (Thr 162 and Thr 163) was converted to that of p38; p38-like ERK2 in which both the CD domain and the ED site were converted to those of p38 ( Fig. 1A ; see also Ref. 23 ). As shown in Fig. 1B , while wild-type ERK2 or ERK2 SD did not bind to CL100, ERK2
TETD slightly bound to CL100, and p38-like ERK2 bound to it more strongly. In contrast, none of the ERK2 constructs were able to bind to MKP-7. As expected, wildtype p38 bound to CL100 strongly, and p38 CDm, in which three aspartic acids of the CD domain (Asp 313, Asp 315 and Asp 316) were replaced by asparagine, did not. As reported previously (24) , wild-type p38, but not p38 CDm bound to MKP-7 (data not shown). Next, we examined the enzymatic activity of CL100. When co-expressed in the cells, p38-like ERK2 was inactivated by CL100 much more efficiently than was wild-type ERK2 (Fig. 1C) . These results clearly show that both the CD domain and the ED site regulate the docking specificity of MAPKs toward CL100.
A possible site on CL100/MKP-1 that interacts with the ED site
Examining the primary sequence of CL100, we noticed another site, near the previously by guest on September 1, 2017
http://www.jbc.org/ Downloaded from identifed site (residues 50 to 58) presumably interacting with the CD domain (22) , that is composed of two positively charged amino acids and surrounding hydrophobic amino acids (residues 71 to 75 of CL100 (human); see Fig. 2A ). We hypothesized that this site is a site corresponding to the ED site, because the ED site of p38 is composed of two negatively charged amino acids. To test this hypothesis, we created a mutant form of CL100 (CL100LMGML), in which two arginine residues (Arg 72 and Arg 74) were replaced by methionines ( Fig. 2A) . While wild-type CL100/MKP-1 bound to p38-like ERK2, CL100LMGML scarcely bound ( and Arg 74 are utilized in the docking interaction between CL100 and MAPKs.
Neither the wild-type nor the LMGML mutant CL100 bound to ERK2. To confirm that the Arg 53, Arg 54 and Arg 55 of CL100, which are suggested to constitute the site corresponding to the CD domain of MAPKs, are essential for docking, we created mutants, in which two or three of these arginines were replaced by methionines (Fig.   3A ). While wild-type CL100 strongly bound to p38 α, CL100MMR or CL100MMM
did not (Fig. 3C ). The docking ability of the both mutants to JNK2 was also reduced compared with wild-type CL100, but the mutants still bound to JNK2 significantly ( Fig. docking mode of p38-like ERK2 is similar to that of p38.
A docking region of CL100/MKP-1
Comparing the primary sequences of the known MKPs, we noticed that the region corresponding to residues 51 to 81 of CL100 is relatively well conserved ( Fig. 4A ) and that the region can be divided into three sub-regions (modules): in the first N-terminal region, a cluster of positively charged residues exists to which the negatively charged amino acids of the CD domain of MAPKs might bind; in the second central region, hydrophobic residues such as leucine, isoleucine and valine are abundant and conserved; in the third C-terminal region, positively charged residues and often surrounding hydrophobic residues exist. The third sub-region is most diverse in the amino acid composition. We hypothesized that this modular structure of an assumed docking surface of MKPs fits the docking groove of MAPKs, and regulates the docking specificity towards MAPKs (Fig. 4B ). To examine whether the residues in each sub-of "LRGML", "LMGRL", "LMGML", "ARGRL", "LRGRA" and "ARGRA").
Generally, the mutations in the third sub-region had severer effects on the interaction with JNK2 than that with p38. For example, while CL100LMGRL bound to p38 as efficiently as wild-type CL100 did, it bound to JNK2 much more weakly than wild-type CL100 did. Next, we mutated arginines in the first and third sub-regions to lysines.
The R to K mutation is supposed to scarcely induce gross conformational changes in the protein, as is the case with the K to R mutation that is routinely used to produce a kinase-dead form of protein kinases in general. As shown in Fig. 5C , while the first sub-region mutants, CL100KKR and CL100KKK, showed a reduced ability to bind to p38, they bound to JNK2 as efficiently as wild-type CL100 did. In contrast, while the third sub-region mutant CL100LKGKL bound to p38 as efficiently as wild-type CL100
did, it showed a reduced ability to bind to JNK2. These results suggest that our results obtained here reflect local changes in the direct docking surface of the protein.
Our results indicate that each sub-regions in the docking region of CL100 are differently utilized in docking interaction with each members of the MAPK family: the first subregion is essential for the docking interaction with p38, but not with JNK; the second sub-region is essential for the docking to both p38 and JNK; the third sub-region is essential for the docking to JNK, but less important for p38. Thus, this region comprising the three sub-regions (residues 51 to 81 of CL100/MKP-1) is utilized in the docking interaction. We call this region a docking surface.
A docking surface of MKP-7 is utilized in docking interaction with MAPKs.
We then examined whether a corresponding region in MKP-7 is also utilized in its docking interaction. MKP-7 is specific for JNK and p38. Wild-type MKP-7 efficiently bound to both p38 and JNK2 ( bind to p38. The latter showed a more decreased ability than the former.
Remarkably, these two mutants bound to JNK2 as efficiently as did wild-type MKP-7
( Fig. 6B) . Thus, the mutations in the first sub-region of MKP-7 induce severer effects on its interaction with p38 than that with JNK. This situation is similar to that in CL100. The third sub-region mutants of MKP-7, MKP-7MHMV and MKP-7KHKA, in which lysines or Val 77 in the third sub-region was mutated, respectively ( Fig. 6A ), bound to p38 as efficiently as did wild-type MKP-7, whereas they showed a decreased ability to bind to JNK2 (Fig. 6B) . Thus, the mutations in the third sub-region of MKP-7 resulted in severer defects in the docking interaction with JNK than with p38. The third sub-region of MKPs is therefore in common important for docking to JNK and is less important for docking to p38. However, for docking to p38, the third sub-region has some more important role in the case of CL100 than in the case of MKP-7.
Efficiency of the enzymatic action of various mutants of CL100/MKP-1 and MKP-7
We measured the enzymatic ability of various mutants of MKPs described above.
When expressed in cells, wild-type CL100 strongly inactivated p38, but CL100MMM, which fails to dock to p38 (see Fig. 5B ) did not inactivate p38 efficiently (Fig. 7A, left) .
Both wild-type CL100 and CL100MMM inactivated JNK2 efficiently; CL100MMM was slightly less effective (Fig. 7A, right) . Wild-type MKP-7 and MKP-7MHML also efficiently inactivated p38, and MKP-7LRR was less effective (Fig. 7B, left) . While wild-type MKP-7 and MKP-7LRR inactivated JNK2 efficiently, MKP-7 MHML had a reduced ability to inactivate JNK2 (Fig. 7B, right) . Collectively, the efficiency of enzymatic ability of various mutants of CL100 and MKP-7 towards p38 and JNK2 (see Examining the primary sequence of the second sub-region (module) of MKPs, we noticed that a charged residue exists in the center of the module (Fig. 4A and 7A ).
MKPs acting on JNK/SAPK and p38 have a negatively charged amino acid (Asp or Glu), and MKPs acting on ERK have a positively charged one (Arg). We discuss later about PAC-1 (see Discussion). JNK/SAPK, but not p38, has a positively charged amino acid near the CD domain in the docking groove ( acids by neutral ones (22) . The CL100KKK mutant, in which all the three arginine residues of the first module were replaced by lysines, had a more decreased ability to bind to p38 than the CL100KKR mutant, in which the first two arginine residues were replaced by lysines (Fig. 5) . On the other hand, the first module does not necessarily forms of MKPs to bind to JNK2 was significantly reduced (Fig. 8B) . Their ability to dock to p38 was not weakened, but was rather strengthened. This may be because p38 has negatively charged amino acids at the corresponding site in the docking groove (see ED site on MAPKs is utilized in some docking interactions, but not in others (26) .
Then, we speculate that the third module is a site corresponding to the ED site (Fig. 9) .
Collectively, the docking surface of MKPs is a strong candidate region corresponding to the docking groove of MAPKs. Our model presented here can explain the molecular basis for the docking specificity towards three major members of MAPKs (ERK, p38
and JNK/SAPK) and further support the model of the docking groove (Fig. 9 ).
We created several chimeric proteins of MKPs, in which their docking surface was Wild-type ERK2 could not bind to CL100, although the docking groove of ERK2 may be able to fit the docking surface of CL100. This may be because the affinity is not strong enough for a tight docking. Then, when the electrostatic interaction is strengthened by adding three more negatively charged amino acids in the docking groove of ERK2, ERK2 becomes to bind to CL100 strongly. In other words, CL100
can inactivate ERK2 when an excess amount of the molecule exists. This might account for the published results showing that CL100 could inactivate ERK2 when overexpressed in cultured cells or Xenopus oocytes (40, 48, 49) . Note that the expression level of CL100 is low in Fig. 1C in the present study. As the docking surface of MKP-7 might not fit the docking groove of ERK2, the docking ability between MKP-7 and ERK2 could not be changed by merely adding three more negatively charged amino acids in the docking groove of ERK2. The fitness might be determined by the overall conformation of the docking surface and/or even the whole molecule. We should also keep it in mind that enzymatic reactions are regulated by their subcellular localization. CL100/MKP-1 is nuclear, and ERK2 is known to translocate from the cytoplasm to the nucleus upon stimulation (39, 50) . Then, these two molecules might accumulate in the nucleus enough to associate with each other, even though their affinity is weak.
Our results presented here show that charged amino acid residues play an important role in determining the binding affinity and specificity of MKPs, and strongly suggest Co-immunoprecipitated Myc-CL100/MKP-1 was detected (αMyc (IP:αHA)). The expression levels of Myc-CL100/MKP-1 were examined (expression). 
